QualityStocksNewsBreaks Archives

MondayJun 22, 2026 1:50 pm

QualityStocksNewsBreaks – Toronto to Host Industry Leaders for a Deep Dive into the Future of Finance

Blockchain Futurist Conference is set to return to Toronto on July 21–22, 2026, bringing together institutions and digital asset leaders to explore emerging advances in finance. The conference will focus on key topics including digital asset regulation, institutional adoption, stablecoins, tokenization, artificial intelligence, compliance, decentralized finance, and digital identity. Featured sessions will include discussions with representatives from organizations such as Bloomberg, JPMorgan, Mastercard, and other industry leaders. Sponsors and partners including AiraPay and Stablecorp will showcase innovations in payments and stablecoin technology, while special programming from organizations such as House of Intelligence and Invest Hong Kong will shine the spotlight…

MondayJun 22, 2026 1:24 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Gains AUKUS Authorization for Permit-Free Defense Technology Transfers

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced it has been registered by the Australian government as an authorized user under the AUKUS licence-free environment, allowing the company to transfer eligible defense technology to approved partners in the United States and United Kingdom without obtaining separate export permits. The designation was established under Australia's Defence Trade Controls Amendment Act 2024 and is intended to streamline technology collaboration among AUKUS member nations. SPARC AI said the authorization is particularly significant for its GPS-denied geolocation and target-acquisition software, providing a direct pathway to integrate the…

MondayJun 22, 2026 1:09 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage Response Cancer Therapies

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) was featured in a BioMedWire editorial examining the rapidly expanding DNA Damage Response inhibitor market, where new drug classes are emerging beyond PARP inhibitors. The company is advancing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target a DNA repair enzyme involved in multiple DNA repair pathways. According to the editorial, Onco-Innovations holds exclusive global rights to a foundational portfolio of PNKP inhibitor technology and is positioning itself as an early leader in a novel class of cancer therapeutics. Onco-Innovations highlighted preclinical data showing ONC010 more than doubled…

MondayJun 22, 2026 12:59 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in Audio Editorial on AI Infrastructure Automation Opportunity

Nightfood Holdings (OTCQB: NGTF) operating through its TechForce Robotics division, was featured in a NetworkNewsAudio Audio Press Release highlighting the growing demand for automation solutions driven by the global buildout of artificial intelligence infrastructure. The editorial notes that major technology companies are expected to invest hundreds of billions of dollars in AI-related infrastructure, creating downstream opportunities for companies providing manufacturing, engineering and precision automation systems. Nightfood Holdings was highlighted for expanding its AI-enhanced robotics platform beyond hospitality applications into pharmaceutical automation, laboratory environments, semiconductor-adjacent manufacturing and AI infrastructure support. The editorial also pointed to the company's recently announced strategic alliance with JJ Enterprise as a move aimed at addressing increasing demand for intelligent…

MondayJun 22, 2026 12:32 pm

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Appoints Chad Levesque as President and Director

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced the appointment of Chad Levesque as president and a member of its board of directors, expanding the company's leadership team as it advances commercial evaluation of its Natural Hydrogen assets in Saskatchewan. Levesque, who has supported MAX Power's capital markets, corporate development and investor relations initiatives since the company became publicly traded in 2022, will continue to lead those efforts while helping broaden awareness of the company's Natural Hydrogen strategy. Figure 1 – Drilling Photo of Lawson Drilling, Genesis…

MondayJun 22, 2026 12:19 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Publishes Updated Investor Materials Highlighting New Drill Targets

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF) announced the publication of an updated corporate fact sheet and investor presentation outlining recently identified drilling locations at its Murdock Mountain Project. The updated materials provide shareholders with new information on exploration targets and their anticipated significance to the company's ongoing exploration program. Nevada Organic Phosphate said the updated fact sheet and presentation include an overview of exploration strategy and progress, summaries of newly identified drilling locations, updated property graphics and a revised capitalization table. The company said the materials are intended to help investors better understand how the…

MondayJun 22, 2026 12:07 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Announces C$5 Million Private Placement to Advance ONC010 Development

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced a non-brokered private placement of 6,764,069 units priced at C$0.7392 per unit for gross proceeds of approximately C$5 million. Each unit consists of one common share and one warrant exercisable at C$0.90 per share for three years. The financing is expected to close on or about July 10, 2026, subject to regulatory approvals, including approval from Cboe Canada. Onco-Innovations said proceeds will be used to advance its ONC010 program through manufacturing and preclinical testing activities, support development of its SynoGraph(TM) platform and provide working capital for general…

MondayJun 22, 2026 11:58 am

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Advances ONC010 Program With Successful 300-Gram API Scale-Up Batch

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced the successful completion of a 300-gram scale-up batch of A83B4C63, the active pharmaceutical ingredient supporting its proprietary ONC010 drug candidate. The batch, produced as part of Dalton Pharma Services' Process Optimization and Intermediate Scale-Up Program, achieved approximately 99.3% purity with no detectable residual solvents following comprehensive quality control and Certificate of Analysis review, marking an important manufacturing milestone for the company's PNKP inhibitor program. Onco-Innovations said the scale-up campaign demonstrates the reproducibility and scalability of the manufacturing process and is expected to support future…

MondayJun 22, 2026 11:45 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention

VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity. VERAXA said the findings, together with previously presented BiTAC-TCE data unveiled at the American Association for Cancer Research Annual Meeting in April 2026, support the potential of two differentiated cancer therapy platforms that may be applicable across multiple solid tumor indications. Management plans to discuss partnering opportunities…

MondayJun 22, 2026 10:30 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), was featured in a BioMedWire editorial highlighting its development of Lucid-MS, a patented, first-in-class drug candidate designed to directly protect the myelin sheath damaged by multiple sclerosis. Unlike conventional MS treatments that primarily target the immune system, Lucid-MS is being developed as a non-immunomodulatory neuroprotective therapy and is preparing to enter Phase 2 clinical trials following successful Phase 1 safety and tolerability studies. The editorial notes that Lucid-MS has demonstrated the ability to prevent and reverse myelin degradation in preclinical…

Site Search

Company Search

Category: QualityStocksNewsBreaks